LabBM Score and Extracranial Score As New Tools for Predicting Survival in Patients with Brain Metastases Treated with Focal Radiotherapy
Open Access
- 11 April 2020
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 12 (4) , e7633
Abstract
Two recently validated, untraditional prognostic scores include serum albumin and lactate dehydrogenase, among other parameters. The latter are hemoglobin, platelet counts, and C-reactive protein (three-tiered LabBM score), whereas the four-tiered extracranial score includes more than one extracranial site of metastatic involvement. Until now, head-to-head comparisons of these two scores in patients treated with focal radiotherapy for newly diagnosed brain metastases are not available. This was a retrospective single-institution analysis of 51 patients, most of whom were managed with first-line stereotactic radiosurgery (SRS). Survival was stratified by the LabBM score and extracranial score. Both scores predicted survival, but the analyses were hampered by small subgroups. In particular, very few patients belonged to the unfavorable groups. Survival shorter than two months, which was recorded in 14%, was not well predicted by the LabBM score and extracranial score. Very few patients treated with focal radiotherapy (largely SRS) had unfavorable prognostic features according to the two untraditional scores, which do not include the number of brain metastases and performance status. Additional research is needed to improve the tools that predict short survival because overtreatment during the terminal phase of metastatic disease continues to represent a relevant issue.Keywords
This publication has 25 references indexed in Scilit:
- Brain metastases from non-small cell lung cancer with EGFR or ALK mutations: A systematic review and meta-analysis of multidisciplinary approachesRadiotherapy and Oncology, 2020
- External Validation of the LabBM Score in Patients With Brain MetastasesJournal of Clinical Medicine Research, 2019
- Predicting prognosis of short survival time after palliative whole-brain radiotherapyJournal of Radiation Research, 2017
- Estimating Survival in Patients With Lung Cancer and Brain MetastasesJAMA Oncology, 2017
- Stereotactic Radiosurgery With or Without Whole-Brain Radiotherapy for Brain MetastasesJAMA Oncology, 2015
- Prognostic Models Predicting Survival of Patients with Brain Metastases: Integration of Lactate Dehydrogenase, Albumin and Extracranial Organ InvolvementClinical Oncology, 2014
- Prognostic scores in brain metastases from breast cancerBMC Cancer, 2009
- The Role of Postoperative Radiotherapy after Resection of a Single Brain MetastasisStrahlentherapie und Onkologie, 2007
- Radiotherapeutic management of brain metastases: A systematic review and meta-analysisCancer Treatment Reviews, 2005
- Relation between local result and total dose of radiotherapy for brain metastasesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995